Brian P Halliday
Overview
Explore the profile of Brian P Halliday including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1007
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tadros R, Zheng S, Grace C, Jorda P, Francis C, West D, et al.
Nat Genet
. 2025 Feb;
57(3):530-538.
PMID: 39966646
Hypertrophic cardiomyopathy (HCM) is an important cause of morbidity and mortality with both monogenic and polygenic components. Here, we report results from a large genome-wide association study and multitrait analysis...
2.
Zheng S, Jurgens S, McGurk K, Xu X, Grace C, Theotokis P, et al.
Nat Genet
. 2025 Feb;
57(3):563-571.
PMID: 39966645
Hypertrophic cardiomyopathy (HCM) is an important cause of morbidity and mortality, with pathogenic variants found in about a third of cases. Large-scale genome-wide association studies (GWAS) demonstrate that common genetic...
3.
Bergan N, Prachee I, Curran L, McGurk K, Lu C, de Marvao A, et al.
Circulation
. 2025 Feb;
151(7):442-459.
PMID: 39895490
Background: Dilated cardiomyopathy (DCM) appears to be diagnosed twice as often in male than in female patients. This could be attributed to underdiagnosis in female patients or sex differences in...
4.
Zheng S, Henry A, Cannie D, Lee M, Miller D, McGurk K, et al.
Nat Genet
. 2024 Nov;
56(12):2646-2658.
PMID: 39572783
Dilated cardiomyopathy (DCM) is a leading cause of heart failure and cardiac transplantation. We report a genome-wide association study and multi-trait analysis of DCM (14,256 cases) and three left ventricular...
5.
Guiding Treatment With Recovered CTRCD: Time to Focus on Definitions of Recovery and Randomized Data
Halliday B, Nazir M
JACC CardioOncol
. 2024 Oct;
6(5):711-713.
PMID: 39479337
No abstract available.
6.
Cheng L, Hammersley D, Ragavan A, Javed S, Mukhopadhyay S, Gregson J, et al.
Eur J Heart Fail
. 2024 Sep;
27(1):113-123.
PMID: 39349993
Aims: In TRED-HF, 40% of patients with recovered dilated cardiomyopathy (DCM) relapsed in the short term after therapy withdrawal. This follow-up investigates the longer-term effects of therapy withdrawal. Methods And...
7.
Hammersley D, Zegard A, Androulakis E, Jones R, Okafor O, Hatipoglu S, et al.
J Am Coll Cardiol
. 2024 Sep;
84(15):1407-1420.
PMID: 39217566
Background: Myocardial fibrosis (MF) forms part of the arrhythmic substrate for ventricular arrhythmias (VAs). Objectives: This study sought to determine whether total myocardial fibrosis (TF) and gray zone fibrosis (GZF),...
8.
Hammersley D, Mukhopadhyay S, Chen X, Jones R, Ragavan A, Javed S, et al.
Eur J Heart Fail
. 2024 Aug;
26(12):2553-2562.
PMID: 39143936
Aims: To assess whether left ventricular (LV) global longitudinal strain (GLS), derived from cardiovascular magnetic resonance (CMR), is associated with (i) progressive heart failure (HF), and (ii) sudden cardiac death...
9.
Jones R, Gruszczyk A, Schmidt C, Hammersley D, Mach L, Lee M, et al.
Nat Cardiovasc Res
. 2024 Apr;
2(8):733-745.
PMID: 38666037
Recurrent myocardial ischemia can lead to left ventricular (LV) dysfunction in patients with coronary artery disease (CAD). In this observational cohort study, we assessed for chronic metabolomic and transcriptomic adaptations...
10.
Javed S, Halliday B
Camb Prism Precis Med
. 2024 Mar;
1:e34.
PMID: 38550947
Precision medicine for cardiomyopathies holds great promise to improve patient outcomes costs by shifting the focus to patient-specific treatment decisions, maximising the use of therapies most likely to lead to...